CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 2,549,897 shares, an increase of 70,145.1% from the April 30th total of 3,630 shares. Based on an average daily trading volume, of 57,447,441 shares, the short-interest ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Down 33.3%

CNBX traded down $0.00 during trading hours on Wednesday, hitting $0.00. 60,582,108 shares of the company’s stock were exchanged, compared to its average volume of 37,521,434. CNBX Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.